← All indications
Phobic Disorders
Anxiety disorders in which the essential feature is persistent and irrational fear of a specific object, activity, or situation that the individual feels compelled to avoid.
Subtype terms (5)
More specific conditions that are subtypes of Phobic Disorders in the MeSH hierarchy.
- Agoraphobia
9 drugs (7 approved, 2 experimental)
- Claustrophobia
- Kinesiophobia
- Phobia, School
- Phobia, Social
56 drugs (41 approved, 15 experimental)
Drugs by status
Approved for this indication (1)
Phase 4 trials (1)
Phase 3 trials (2)
Phase 2 trials (3)
Other trials (2)
Organizations
Organization Involved with Phase 4 Indications (9)
Organization Involved with Phase 3 Indications (6)
Organization Involved with Phase 2 Indications (18)
- Shire
- Pherin Pharmaceuticals, Inc.
- National Center for Complementary and Integrative Health (NCCIH)
- Baylor University
- Case Western Reserve University
- Indiana University
- University of Kansas
- University of Bern
- Yale University
- Columbia University
- University of Basel
- Icahn School of Medicine at Mount Sinai
- University of Munster
- The Medical Research Network, LLC
- American Psychological Foundation
- American Psychological Association
- Dean Foundation
- Johnson and Johnson
Organization Involved with Other Experimental Indications (4)